Stocktoria
Jin Medical International Ltd. ZJYL
Jin Medical International Ltd. (ZJYL) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $20.7M at a 5.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.17 — grey zone (between the usual thresholds). A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.381 |
| Retained earnings / assets | 0.392 |
| EBIT / assets | 0.011 |
| Equity / liabilities | 1.246 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ZJYL | Jin Medical International Ltd. | 4/9 | 5.16 | 15.7 | -12% |
| LFWD | Lifeward Ltd. | 4/9 | — | — | -14.1% |
| MLSS | MILESTONE SCIENTIFIC INC. | 2/9 | — | — | — |
| FEED | ENvue Medical, Inc. | 2/9 | -6.2 | — | — |
| CLGN | CollPlant Biotechnologies Ltd | 3/9 | — | — | — |
| NTRB | NutriBand Inc. | 3/9 | -15.84 | — | — |
| AVR | Anteris Technologies Global Corp. | 2/9 | — | — | — |
About Jin Medical International Ltd.
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. It operates in the Mainland China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. operates as a subsidiary of Jolly Harmony Enterprises Limited.
FAQ
Is ZJYL financially healthy?
Jin Medical International Ltd.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does ZJYL pay a dividend?
No, Jin Medical International Ltd. does not currently pay a dividend.
How profitable is ZJYL?
In FY2025, Jin Medical International Ltd. had a net margin of 5.8% and a return on equity of 4.0%.
What is ZJYL's P/E ratio?
Jin Medical International Ltd.'s trailing price-to-earnings (P/E) ratio is about 15.7×, based on its latest annual earnings.
Is ZJYL a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Jin Medical International Ltd.: a Piotroski F-score of 4/9, an Altman Z″ in the safe zone, a P/E of about 15.7×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.